Wnt signaling in ankylosing spondylitis (Q38211262)

31 August 2017

title

Wnt signaling in ankylosing spondylitis (English)

1 reference

31 August 2017

Maripat Corr

1

1 reference

31 August 2017

publication date

13 May 2014

1 reference

31 August 2017

published in

Clinical Rheumatology

1 reference

31 August 2017

volume

33

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

759-762

1 reference

To Wnt or not to Wnt: the bone and joint health dilemma

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

The opposing roles of Wnt-5a in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Inhibition of adipogenesis by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2663-6

Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis

21 January 2018

1 reference

12 December 2020

Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis

1 reference

12 December 2020

Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020

High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis

1 reference

12 December 2020

10.1007/S10067-014-2663-6

Identifiers

DOI

1 reference

31 August 2017

1 reference